Comparing Two Tests for Colorectal Cancer Screening
Author Information
Author(s): G Castiglione, M Zappa, G Grazzini, A Mazzotta, M Biagini, P Salvadori, S Ciattol
Primary Institution: Centro per lo Studio e la Prevenzione Oncologica
Hypothesis
Is the immunochemical test Hemeselect more effective than the guaiac test Hemoccult in detecting colorectal cancer in a population-based screening program?
Conclusion
Hemeselect is superior to Hemoccult as it is at least as effective but more efficient and acceptable than guaiac testing.
Supporting Evidence
- Hemeselect detected more cancers and adenomas compared to Hemoccult.
- The positive predictive value for cancer was higher for Hemeselect.
- Hemeselect requires no dietary restrictions, increasing compliance.
Takeaway
This study looked at two tests to find out which one is better at spotting colorectal cancer. The new test, Hemeselect, works better and is easier for people to use.
Methodology
The study compared the accuracy of Hemeselect and Hemoccult in a population-based screening program for colorectal cancer, involving 8008 subjects aged 40-70.
Potential Biases
Potential self-selection bias and differences in dietary restrictions could affect the results.
Limitations
The study may have biases due to self-selection and dietary restrictions affecting compliance.
Participant Demographics
3784 males and 4224 females, mean age around 54 years.
Statistical Information
P-Value
p<0.00001
Confidence Interval
95% confidence intervals calculated for proportions.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website